Glucotrack, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
GCTK$1.39-32.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
(in thousands of US Dollars except share data)
| In thousands of US Dollars (except share data) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common Stock · Accumulated | |||||||||
| Numbers of Shares · Amount · Additional Paid-in Capital · Receipts on account of shares · Other Comprehensive Income · Accumulated Deficit · Total Stockholders’ Equity | |||||||||
| Balance as of December 31, 2025 (Audited) | 910,688 | $1 | $151,080 | $3,544 | $41 | $(151,838) | $2,828 | ||
| Loss for the period | - | - | - | - | - | (8,148) | (8,148) | ||
| Other comprehensive income | - | - | - | - | 11 | - | 11 | ||
| Stock-based compensation | - | - | 120 | - | - | - | 120 | ||
| Issuance of common stock for debt | 2,195,000 | 2 | 1,753 | - | - | - | 1,755 | ||
| Exercise of warrants into common stock | 60,000 | -(*) | -(*) | - | - | - | - | ||
| Issuance of common stock upon exercise of pre-funded warrants | 1,033,591 | 1 | 3,544 | (3,544) | - | - | 1 | ||
| Issuance of common stock upon completion of ELOC financing, net of offering expenses | 2,060,000 | 2 | 1,690 | - | - | - | 1,692 | ||
| Balance as of June 30, 2026 (Unaudited) | 6,259,279 | $6 | $158,187 | $ | - | $52 | $(159,986) | $(1,741) | |
| Balance as of December 31, 2024 (Audited) | 13,409 | $ | -(*) | $119,230 | $228 | $(8) | $(132,450) | $(13,000) | |
| Loss for the period | - | - | - | - | - | (11,589) | (11,589) | ||
| Other comprehensive income | - | - | - | - | 49 | - | 49 | ||
| Stock-based compensation | - | - | 80 | - | - | - | 80 | ||
| Issuance of common stock upon the completion of public offerings, net of offering expenses of $539 | 665,052 | 1 | 10,714 | - | - | - | 10,715 | ||
| Stock split adjustment | 58,886 | -(*) | - | - | - | - | - | ||
| Cashless exchange of warrants into common shares | 162,063 | -(*) | 20,625 | - | - | - | 20,625 | ||
| Balance as of June 30, 2025 (Unaudited) | 899,410 | $1 | $150,649 | $228 | $41 | $(144,039) | $6,880 | ||
| Balance as of March 31, 2026 (Unaudited) | 2,524,279 | $3 | $155,274 | $ | - | $44 | $(156,172) | $(851) | |
| Loss for the period | - | - | - | - | - | (3,814) | (3,814) | ||
| Other comprehensive income | - | - | - | - | 8 | - | 8 | ||
| Stock-based compensation | - | - | 59 | - | - | - | 59 | ||
| Issuance of common stock for debt | 2,195,000 | 2 | 1,753 | - | - | - | 1,755 | ||
| Exercise of warrants into common stock | 60,000 | -(*) | -(*) | - | - | - | - | ||
| Issuance of common stock upon completion of ELOC financing, net of offering expenses | 1,480,000 | 1 | 1,101 | - | - | - | 1,102 | ||
| Balance as of June 30, 2026 (Unaudited) | 6,259,279 | $6 | $158,187 | $ | - | $52 | $(159,986) | $(1,741) | |
| Balance as of March 31, 2025 (Unaudited) | 426,648 | $ | -(*) | $146,290 | $228 | $28 | $(139,283) | $7,263 | |
| Loss for the period | - | - | - | - | - | (4,756) | (4,756) | ||
| Other comprehensive income | - | - | - | - | 13 | - | 13 | ||
| Stock-based compensation | - | - | 40 | - | - | - | 40 | ||
| Issuance of common stock upon the completion of public offerings, net of offering expenses | 414,785 | -(*) | 4,319 | - | - | - | 4,320 | ||
| Stock split adjustment | 57,977 | -(*) | - | - | - | - | - | ||
| Balance as of June 30, 2025 (Unaudited) | 899,410 | $1 | $150,649 | $228 | $41 | $(144,039) | $6,880 | ||
| (*) | Represents amount lower than $1. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.